NITROMED
NitroMed is an emerging pharmaceutical company that discovers, develops and seeks to commercialize proprietary pharmaceuticals based on the therapeutic benefits of the naturally-occurring molecule nitric oxide. NitroMed is conducting a late-stage confirmatory trial of our lead nitric oxide-enhancing drug, BiDil, for the treatment of heart failure in African Americans.
NITROMED
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1987-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.nitromed.com
Total Employee:
101+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
51.3 M USD
Technology used in webpage:
Google Apps For Business Network Solutions DNS FutureQuest
Current Advisors List
Current Employees Featured
Stock Details
Investors List
HealthCare Ventures
HealthCare Ventures investment in Series E - NitroMed
Morgan Stanley Expansion Capital
Morgan Stanley Expansion Capital investment in Series E - NitroMed
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series E - NitroMed
Rho Ventures
Rho Ventures investment in Series E - NitroMed
Care Capital
Care Capital investment in Series E - NitroMed
Quintiles
Quintiles investment in Series E - NitroMed
Boston University Technology Development Fund
Boston University Technology Development Fund investment in Series E - NitroMed
Official Site Inspections
http://www.nitromed.com
- Host name: 69.5.14.68
- IP address: 69.5.14.68
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
